Completed Clinical Trials

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

By April 24, 2017No Comments

Condition

Malignant Mesothelioma

Estimated Enrollment: 69

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: NCCTG-N0021|CDR0000068659

Study First Received: June 6, 2001

Last Updated: December 5, 2016

Estimated Primary Completion Date: August 2004

 

Primary Outcome Measures:

time to progression|survival|quality of life

Sponsors and Collaborators:

Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT00017186

Leave a Reply

Call Now ButtonCall Now